Tillbaka till alla evenemang

Föreläsning med Dr Szabo - From Mind-Bending to Cell-Mending: Psychedelic Insights from Cell to Soul | Facebook

  • 30 Greta Arwidssons Väg Stockholm, Stockholms län, 114 19 Sweden (se karta)

Varmt välkomna på denna spännande föreläsning med Dr. Attila Szabo om psykedelikas anti-inflammatoriska, anti-stress och neuroimmuna effekter!

Föreläsningen sker på engelska, är öppen för allmänheten och kommer följas av en Q&A med Dr. Szabo. Plats för föreläsningen: Campus Albano, hus 2, lärosal 16 (Greta Arwidssons väg 30, Stockholm).

Om Dr. Attila Szabo:
"Dr. Attila Szabo is a Research Fellow at the Norwegian Centre for Mental Disorders Research (NORMENT), University of Oslo, Norway. He holds two Master’s degrees in Biochemistry (MSc) and in Philosophy (MA). His research interest involves psychoneuroimmunology, immunopsychiatry, biological psychiatry and the molecular biology of inflammation. He is also interested in the philosophical questions of mind-body interaction, psychosomatic phenomenon and the phenomenology of altered states of consciousness. Besides academia, Attila is a founding member of the Norwegian Association for Psychedelic Science (Norsk Forening for Psykedelisk Vitenskap, NFPV) and is Editor-in-Chief of the Journal of Psychedelic Studies"

Om föreläsningen:
"With the advent of the Psychedelic Renaissance, psychedelic research is making significant strides in revolutionizing our understaing of the mind. However, most studies in the field are directed to assess potential therapeutic uses of these substances in clinical psychology and psychiatry. These investigations have primarily focused on understanding their psychotherapeutic use, overlooking their impact on physiological processes at systemic and cellular levels. Only recently has biomedical research delved into the somatic effects of psychedelics. The lecture aims to address this knowledge gap by discussing the biology underlying psychedelics' therapeutic effects in illnesses including autoimmunity, stroke, traumatic brain injury, neurodegenerative disorders and dementias. We will focus on both classic (e.g. DMT, psilocybin) and non-classic psychedelics (e.g. muscimol, ibogaine, etc.)."

Föregående
Föregående
10 maj

Välkommen till PS24 Östersund!

Nästa
Nästa
18 maj

Psykedeliskt Forum 2024